中新集團:擬斥5000萬元參投智能叁號、醫療叁號
格隆匯2月10日丨中新集團(601512.SH)公佈,公司擬作為有限合夥人參與由蘇州工業園區原點治則創業投資管理中心(有限合夥)(“原點治則”)發起設立的蘇州工業園區元禾原點智能叁號產業投資企業(有限合夥)(智能叁號)、蘇州工業園區元禾原點醫療叁號產業投資企業(有限合夥)(醫療叁號)並以現金貨幣方式分別向智能叁號、醫療叁號出資2500萬元,分別佔比不超過智能叁號、醫療叁號最終認繳總額的5%,資金來源均為本公司自有資金。智能叁號、醫療叁號採用有限合夥形式設立,規模分別不低於人民幣5億元且不超過人民幣7.5億元。
智能叁號主要投資於先進技術、智能製造、供應鏈升級等創業企業;醫療叁號主要投資於生物技術和醫療健康領域中的新藥研發、診斷試劑和醫療器械等創業企業。
此次投資符合公司戰略發展方向,有助於整合利用各方優勢,發掘投資機會,有效促進和補充公司主業,從而提升公司產業園區開發運營的核心競爭力。此次投資對公司的財務及經營狀況不會產生重大影響,符合有關法律、法規和公司章程的規定,符合公司及全體股東的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.